期刊文献+

半乳糖凝集素-3在垂体腺瘤的表达及意义

下载PDF
导出
摘要 目的 研究半乳糖凝集素-3(Galectin-3)与垂体腺瘤侵袭性的关系.方法 用免疫组织化学技术S-P法检测Galectin-3在63例垂体腺瘤的表达,并将38例PRL腺瘤分为侵袭组和非侵袭组,分析两组之间的表达差异.结果 (1)Galectin-3在38例PRL腺瘤中有28例表达(73.68%),10例ACTH腺瘤中有4例表达(40.00%),其他类型的垂体腺瘤均未见表达,在正常垂体组织无表达.(2)PRL腺瘤侵袭组与非侵袭组的阳性表达率为92.0%(23/25)和38.46%(5/13),两组之间差异有统计学意义(P〈0.01).结论 Galectin-3在不同类型垂体腺瘤有不同的表达,Galectin-3的表达与PRL腺瘤的侵袭性密切相关. Objective To study the expression of galectin - 3 in pituitary adenoma and investigate the relationship between its expression and invasiveness. Methods The expression Of galactin - 3 of 63 pituitary adenoma were examined by streptavidin/ peroxidase (S -P)immunohistochemical technique, and the 38 cases of prolactinoma were divided into the invasive and noninvasive group. Results ( 1 ) Galectin - 3 was expressed in 28 of 38 (73, 68% ) prolaetinoma, and 4 of 10 ACTH adenoma, but not expressed in other type of adenoma, Galectin - 3 is negative in normal pituitary. (2) The positive rate of galectin - 3 expression in invasive prolactinoma and non -invasive group was 92% (23/25), 38. 46% (5/13) respectively. Significant difference was found between the two groups ( P 〈 0. 01 ). Conclusions There is a differential expression of galectin - 3 in pituitary adenoma. The expression Of galectin - 3 in prolactinoma is closely related to its invasiveness.
出处 《浙江临床医学》 2012年第1期1-3,共3页 Zhejiang Clinical Medical Journal
关键词 垂体腺瘤 半乳糖凝集素-3 免疫组织化学 pituitary adenoma Galectin - 3 Immunohistochemistry
  • 相关文献

参考文献10

  • 1Fukumori T,Takenaka Y,Yoshii T,et al.CD29 and CD7 mediate galectin-3 induced type Ⅱ T cell apoptosis.Cancer research,2003,6(23):8302-8311. 被引量:1
  • 2Hardy J,Vezina JL.Transsphenoidal neurosurgery of intracranial neoplasm.Adv Neurol,1976,15:261-273. 被引量:1
  • 3Knosp E,Steiner E,Kitz K,et al.Pituitary adenomas with invasion of the cavernous sinus space:a magnetic resonance imaging classification compared with surgical findings.Neurosurgery,1993,33(4):610-618. 被引量:1
  • 4魏海燕,王春友.Gal-3与Bcl-2、层粘连蛋白受体在胰腺癌中表达的关系及意义[J].临床消化病杂志,2003,15(2):59-61. 被引量:5
  • 5Barondes SH,Cooper DN,Gitt MA,et al.Galectins:structure and function of a large family of animal lectins.J Biol Chem,1994,269:20807-20810. 被引量:1
  • 6Bresalier RS,Yan PS,Byrd JC,et al.Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system.Cancer,1997,80(4):776-787. 被引量:1
  • 7贾万钧,郭艳.CK19、gal-3、HBME-1和Ret蛋白在甲状腺乳头状癌中的表达[J].浙江临床医学,2007,9(11):1443-1444. 被引量:5
  • 8Plzak J,Betka J,Karel S,et al.Galectin-3–an emerging prognostic indicator in advanced head and neck carcinoma.European Journal of Cancer,2004,40:2324-2330. 被引量:1
  • 9Riss D,Jin L,Qian X,et al.Differential expression of galectin-3 in pituitary tumors.Cancer research,2003,63(1):2251-2255. 被引量:1
  • 10Katharina H,Ruebel L,Qian X,et al.Effects of DNA methylation on galectin-3 expression in pituitary tumors.Cancer research,2005,65(4):1136-1140. 被引量:1

二级参考文献9

  • 1王川,张祥福,杨发端,卢辉山,殷凤峙.nm23基因产物/NDPK在大肠癌中的表达及其临床意义[J].中华病理学杂志,1995,24(6):356-358. 被引量:31
  • 2Rosai J, Zampi G, Careangiu ML. Papillary carcinoma of the thyroid a discussion of its several morphologic expressions with particular emphasis on the follicular variant. Am J Surg Pathol, 1983,7: 809-817. 被引量:1
  • 3Liberman E, Weidner N. Papillary and follicular neoplasms of the thyroidgland. Differential immunohistochemical staining with highmolecular-weight keratin and involucrin. Appl Immunohistochem Molecul Morphol,2000,8:42-48. 被引量:1
  • 4Chetmg CC, Ezzat S, Freeman JL, et al. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol,2001,14:338-342. 被引量:1
  • 5Miettinen M, Kovatich AJ, Karkkainen P. Keratin subsets in papillary and follicular thyroid lesions: A paraffin section analysis with diagnosis implications. Vichows Arch, 1997,431:407-413. 被引量:1
  • 6Baloch ZW, Abraham S, Roberts S, et al. Differential expression of cytokeratins in follicular variant papillary carcinoma; an imunohistochemical study and its diagnostic utility. Hum Pathol, 1999,30: 1166- 1171. 被引量:1
  • 7Inohara H, Honjo Y, Yoshii T, et al. Expression of galectin - 3 in fine needle apirates as a marker differentiating benign from malignant thyroid neoplasms. Cancer, 1999,85:2475-2481. 被引量:1
  • 8Van- Hoeven KH, Kovatich AJ, Miettinen M. Immunocytochemical evaluation of HBME - 1, CA19 -9, and CD- 15(Leu- M1)in fine needle aspirates d thyroid nodules. Diagn Cytopathol, 1998,18:93 - 97. 被引量:1
  • 9Hirokawa M, Horiguchi H, Wakatsuki S, et al. Intranodal benign thyroid tissue; significance of HBME - 1 in differentiation from metastatic papillary thyroid carcinoma. APMIS, 2001,109 : 875-880. 被引量:1

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部